Interesting, page-2693

Ok, Firstly, I must declare that I didn't know who IBX was until more recent times - First invested in May - June 2020
when the sp was fluctuating between 2.2 - 2.9 c.

Regardless, I do believe that further marketing and promotion will once again be ramped up during/after human
trials. It's always the objective of spec company's to provide a positive spin on potential - within the rules afforded
to them by the regulators.

The objective of being a publicly listed co, after all, is access to capital to pursue an objective and the way to
minimise the cost of capital and the dilution of equity is to continue to promote and market the co, within the
rules of course.